Drug Database
Back to search

Belgium· BE-AMP-SAM410627-00

Adapalene IPS 0,1 %

A adapalene product containing adapalene, registered in Belgium by International Pharmaceutical Services. The same ATC class is registered in 16 of our 19 countries.

ATC D10AD03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedAdapalene IPS 0,1 %ATCD10AD03REGISTER NO.BE-AMP-SAM410627-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about adapaleneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Adapalene is registered in 16 of 19 countries.

Countries holding a registration under ATC D10AD03 (adapalene), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search adapalene products by name

Adapalene · ATC D10AD03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Adapalene
Manufacturer
International Pharmaceutical Services
Country
Belgium (BE)
ATC code
D10AD03
ATC class
Adapalene
Defined daily dose
1 mg, T
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for adapalene.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check adapalene against other medicinesHow interaction checks work

Adapalene · interactions on record

80 records

  • 1 severe
  • 8 moderate
  • 71 info

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • Salicylic acidD01AE12moderate
  • IsotretinoinD10AD04moderate
  • Benzoyl peroxideD10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Adapalene in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All adapalene products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Differin
  • Cyprus · Adaferin
  • Czechia · Belakne, Differine
  • Germany · Differin, Dipalen
  • Denmark · Redap
  • Estonia · Differin
  • Spain · Differine
  • Finland · Differin
  • France · Adapalene Teva, Adapalene Zentiva
  • United Kingdom (Northern Ireland) · Differin
  • Greece · Adaferin
  • Croatia · Sona
  • Hungary · Differin
  • Ireland · Differin
  • Iceland · Differin
  • Italy · Differin
  • Lithuania · Differin
  • Luxembourg · Differin
  • Latvia · Differin
  • Malta · Differin
  • Netherlands · Differin
  • Norway · Differin
  • Poland · Acnelec, Differin
  • Portugal · Differin
  • Sweden · Differin
  • Slovenia · Belakne
  • Slovakia · Belakne, Differine

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c6eb498e-cfc4-4e8a-8fc9-f9e8c03f340b
GET /v1/drugs/c6eb498e-cfc4-4e8a-8fc9-f9e8c03f340b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Gel",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Adapalene IPS 0,1 %",
  "name_fr": "Adapalene IPS 0,1 %",
  "name_nl": "Adapalene IPS 0,1 %",
  "amp_code": "SAM410627-00",
  "strengths": [
    "1.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Adapalene"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Adapalene",
  "authorisation_numbers": [
    "1262PI0069F007"
  ]
}
API referenceMCP serverPlans

See everything about adapalene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console